Hutch News

Hutch News

Stories tagged 'hiv vaccine trials network'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Sept. 7, 2017

A common, normally dormant virus called cytomegalovirus can make matters worse for patients with critical illness — and a new study by Fred Hutch's Dr. Michael Boeckh and colleagues at the University of Washington hints that preventing the virus from reawakening in these critical moments could stem some of its harm.

View story >


Will the flu vaccine work for you? Answer may be in your genes

Set of 9 genes that predicts flu response in adults under 35 could be first step to personalized vaccine

Aug. 31, 2017 | By Rachel Tompa / Fred Hutch News Service

A newly uncovered set of genes that predicts whether the flu shot will work or not could be the first step toward a personalized flu vaccine.

View story >


Community-building leads to record enrollment in HIV prevention study

Fighting the stigma of HIV among communities of color takes trust — and time

Aug. 4, 2017 | By Mary Engel / Fred Hutch News Service

Vic Sorrell knows that the secret behind a successful HIV prevention study is spending the time to establish relationships and earn trust. A pioneer in community engagement, Sorrell works for the Vanderbilt HIV Vaccine Program, a unit of the Fred Hutch-based HIV Vaccine Trials Network.

View story >


Training tomorrow's HIV researchers

With no end yet to the pandemic, a program supports young South African physician-scientists

June 12, 2017 | By Mary Engel / Fred Hutch News Service

Dr. Nishila Moodley receives an award from her mentor, internationally acclaimed HIV researcher Dr. Glenda Gray, as the first graduate of the South African HVTN AIDS Vaccine Early Stage Investigator Programme.

View story >


'We've become full partners'

An HIV laboratory in South Africa advances scientific understanding, and more

Jan. 6, 2017 | By Mary Engel / Fred Hutch News Service

Fred Hutch immunologist Dr. Erica Andersen-Nissen moved to Cape Town, South Africa, in 2013 to set up a state-of-the-art HIV laboratory to anchor two groundbreaking vaccine clinical trials. This is the story of building that lab, from the people up.

View story >


On World AIDS Day, renewed hope for an HIV vaccine

Clinical trial taking place in South Africa could 'dramatically alter the course of the pandemic’

Dec. 1, 2016 | By Mary Engel / Fred Hutch News Service

World’s AIDS Day 2016 brings especially hopeful news: A large-scale clinical trial has opened in South Africa to test an experimental HIV vaccine regimen that could lead to the first licensed vaccine against the virus that causes AIDS.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.